Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
630.00    30.00 (5.00%)
Bid:
626.00
Ask:
634.00
Spread: 8.00 (1.278%)
Market Cap: £762.36m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

Block Listing Return

2 Jan 2025 07:00

RNS Number : 8214R
Oxford Biomedica PLC
02 January 2025
 

For Immediate Release

2 January 2025

 

OXFORD BIOMEDICA PLC

 

BLOCK LISTING RETURN

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

1 July 2024

To:

31 December 2024

Balance of unallotted securities under scheme(s) from previous return:

294,719

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

11,197

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

283,522

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 and 2024 Long Term Incentive Plan

Period of return:

From:

1 July 2024

To:

31 December 2024

Balance of unallotted securities under scheme(s) from previous return:

393,299

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

600,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

433,280

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

560,019

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 and 2024 Deferred Bonus Plan

Period of return:

From:

1 July 2024

To:

31 December 2024

Balance of unallotted securities under scheme(s) from previous return:

286,791

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

300,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

211,730

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

375,061

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Sharesave Scheme

Period of return:

From:

1 July 2024

To:

31 December 2024

Balance of unallotted securities under scheme(s) from previous return:

339,753

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

713

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

339,040

 

Name of contact:

Natalie Walter, Company Secretary

Telephone number of contact:

01865 783000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRUAUNRVSUARAR
Date   Source Headline
5th Nov 20242:23 pmRNSGrant of options
4th Nov 202410:56 amRNSHolding(s) in Company
1st Nov 20247:00 amRNSTotal Voting Rights
31st Oct 20247:00 amRNSHolding(s) in Company
21st Oct 20249:47 amRNSBlock Listing Application
4th Oct 20243:25 pmRNSGrant of Options
3rd Oct 20244:05 pmRNSHolding(s) in Company
1st Oct 20245:33 pmRNSHolding(s) in Company
1st Oct 20247:00 amRNSTotal Voting Rights
23rd Sep 20247:00 amRNSInterim Results
2nd Sep 20247:00 amRNSLucinda Crabtree joins OXB as CFO today
2nd Sep 20247:00 amRNSTotal Voting Rights
9th Aug 202411:01 amRNSDirector Declaration
8th Aug 20247:00 amRNSHalf Year Trading Update and Notice of Results
1st Aug 20247:00 amRNSTotal Voting Rights
30th Jul 20244:51 pmRNSDirector Declaration
29th Jul 20244:31 pmRNSDirector Declaration
25th Jul 20247:00 amRNSOXB Appoints Non-Executive Director
25th Jul 20247:00 amRNSBlock Listing Application
22nd Jul 20247:00 amRNSHolding(s) in Company
17th Jul 20247:00 amRNSOXB announces CFO transition
3rd Jul 20249:19 amRNSPerson Closely Associated Dealing
1st Jul 202411:24 amRNSBLOCK LISTING RETURN
1st Jul 20247:00 amRNSTotal Voting Rights
28th Jun 20244:02 pmRNSHolding(s) in Company
27th Jun 20241:57 pmRNSPerson Closely Associated Dealing
24th Jun 20245:44 pmRNSResult of Annual General Meeting
21st Jun 20243:11 pmRNSHolding(s) in Company
20th Jun 202412:24 pmRNSHolding(s) in Company
20th Jun 202410:45 amRNSHolding(s) in Company
20th Jun 20249:15 amRNSHolding(s) in Company
19th Jun 20248:00 amRNSAdmission of Shares and Total Voting Rights
18th Jun 20247:00 amRNSSubscription of shares by Institut Mérieux
3rd Jun 20247:00 amRNSTotal Voting Rights
15th May 20243:52 pmRNS2024 Annual General Meeting Notification
1st May 20247:00 amRNSTotal Voting Rights
30th Apr 20245:00 pmRNS2023 Annual Report and Accounts
29th Apr 20249:38 amRNSPrelim Results for Y/E 2023 - REPLACEMENT
29th Apr 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
2nd Apr 20247:00 amRNSTotal Voting Rights
20th Mar 20247:00 amRNSUpdate on CDMO Services
11th Mar 20247:00 amRNSBoard Changes
5th Mar 20247:00 amRNSUpdated Financial Guidance and 2023 Trading
1st Mar 20247:00 amRNSTotal Voting Rights
15th Feb 20247:00 amRNSAppointment of Joint Corporate Broker
1st Feb 20244:48 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSTotal Voting Rights
31st Jan 20247:00 amRNSBlock Listing Application
30th Jan 20247:00 amRNSTotal Voting Rights
29th Jan 20248:38 amRNSCompletion of Transaction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.